Evidence map›Paper›PMID 41030991›Full record

ArticlebioRxiv : the preprint server for biology2025

Knockout of P2Y12 receptor facilitates microglia-neuron body-to-body interactions and accelerates prion disease.

Natallia Makarava, Tarek Safadi, Olga Bocharova, Olga Mychko, Narayan P Pandit, Kara Molesworth, Ukpong B Eyo, Ilia V Baskakov

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Natallia MakaravaCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Tarek SafadiCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Olga BocharovaCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Olga MychkoCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Narayan P PanditCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kara MolesworthCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ukpong B EyoDepartment of Neuroscience, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0002-1294-475X
Ilia V BaskakovCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-2821-0942

Funding

Self-Propagating Mechanism of Prion DiseasesR01NS045585 · NINDS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI Ilia V Baskakov · 2003 to 2026
$9.6M
Role of reactive astrocytes in prion diseasesR01NS129502 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI Ilia V Baskakov · 2023 to 2026
$2.5M
NINDS NIH HHS R01 NS045585NINDS NIH HHS R01 NS129502
6 · The paper itself

Abstract

Microglia continuously monitor neuronal health through somatic purinergic junctions, where microglial processes establish dynamic contacts with neuronal cell bodies. The P2Y12 receptor is a key component of these junctions, essential for intercellular communication between ramified microglia and neurons under homeostatic conditions. While P2Y12 has long been considered a marker of homeostatic microglia, its potential role in reactive microglia during neurodegenerative disease remains largely unexplored. In this study, we demonstrate that P2Y12 deletion significantly reduces microglia-neuron process-to-body contacts in adult mice, consistent with previous findings. However, unexpectedly, P2Y12 loss markedly increases microglia-neuron body-to-body contacts, revealing an alternative mode of microglia-neuron communication independent of P2Y12. In prion-infected mice, P2Y12 expression persists in reactive, amoeboid microglia during advanced disease stages, including those engaging in extensive neuronal envelopment. Notably, P2Y12 loss increases the prevalence of envelopment events and accelerates disease progression. These findings redefine the role of P2Y12 in neurodegeneration, suggesting that its progressive decline lowers the threshold for microglia-neuron body-to-body interactions, ultimately influencing disease trajectory.

Identifiers

PMID41030991
PMCPMC12478366

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.